Redox Paradox of Polyphenols: Bioavailability, Hormesis, and Safety Concerns
Phytotherapy Research · 2026-05 · 40 (5) · 2437-2455
DOI: 10.1002/ptr.70268 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 16.02.2026. Verfasst von Stanislava Vrankova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic. Hauptthemen laut MEDLINE: Polyphenols, Antioxidants. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 143 Literaturangaben. Gefördert von: Scientific Grant Agency of the Ministry of Education of Slovak Republic, Vedecká Grantová Agentúra MŠVVaŠ SR a SAV.
Abstract (Originalsprache)
Polyphenols are widely recognized for their antioxidant, anti‐inflammatory, and disease‐preventive properties, yet accumulating evidence highlights a paradoxical nature of their biological activity. At physiological dietary levels, polyphenols exert beneficial effects through modulation of redox homeostasis, signaling pathways, and protective enzyme systems. However, high‐dose supplementation or pharmacological use may disrupt cellular balance, leading to pro‐oxidant activity, enzyme inhibition, endocrine disruption, and organ toxicity. This review summarizes current knowledge on the dual effects of polyphenols, emphasizing their hormetic dose–response behavior and the context‐dependent outcomes of their intake. Adverse outcomes have been reported across experimental and clinical studies. These include carcinogenic effects, impaired iron absorption resulting in anemia, thyroid hormone disturbances, hepatotoxicity, nephrotoxicity, and gastrointestinal intolerance. Mechanistic pathways involve mainly metal ion chelation, cytochrome P450 interference, and the formation of reactive quinone intermediates that bind protein thiols, deplete glutathione, and increase reactive oxygen species. Such processes compromise redox balance, alter cellular signaling, and may exacerbate underlying disease states. These findings underscore the need for a nuanced understanding of polyphenol biology beyond their presumed antioxidant role. Future research should prioritize dose–response characterization, mechanistic clarification of pro‐oxidant and endocrine‐disrupting effects, and rigorous clinical evaluation of long‐term safety. Optimizing the health benefits of polyphenols will require dosing strategies informed by their hormetic nature, variable bioavailability, and individual physiological context, ensuring efficacy without triggering harmful side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic.
- Faculty of Medicine, Institute of Pathophysiology, Comenius University, Bratislava, Slovak Republic.
Förderung
- Scientific Grant Agency of the Ministry of Education of Slovak Republic
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
Zitieren
APA
Vrankova, S., Cebova, M., Klimentova, J., & Pechanova, O. (2026). Redox Paradox of Polyphenols: Bioavailability, Hormesis, and Safety Concerns. Phytotherapy Research, 40(5), 2437-2455. https://doi.org/10.1002/ptr.70268
Vancouver
Vrankova S, Cebova M, Klimentova J, Pechanova O. Redox Paradox of Polyphenols: Bioavailability, Hormesis, and Safety Concerns. Phytotherapy Research. 2026;40(5):2437-2455. doi:10.1002/ptr.70268
BibTeX
@article{Vrankova2026,
author = {Vrankova, Stanislava and Cebova, Martina and Klimentova, Jana and Pechanova, Olga},
title = {Redox Paradox of Polyphenols: Bioavailability, Hormesis, and Safety Concerns},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {5},
pages = {2437--2455},
doi = {10.1002/ptr.70268}
}
EUVIMED